S'abonner

A closer look at same-day bidirectional endoscopy - 23/08/11

Doi : 10.1016/j.gie.2008.04.063 
Jennifer Urquhart, MD ⁎, Glenn Eisen, MD, MPH, Douglas O. Faigel, MD, Nora Mattek, MPH, Jennifer Holub, MA, MPH, David A. Lieberman, MD
Current affiliations: Oregon Health and Science University, Department of Gastroenterology, Veterans Administration Portland Medical Center, Portland, Oregon, USA 

Reprint requests: Jennifer Urquhart, MD, Department of Gastroenterology, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd, Mailcode L-461, Portland, OR 97239.

Portland, Oregon, USA

Abstract

Background

Same-day bidirectional endoscopy (BDE) is commonly used in clinical practice.

Objective

Our purpose was to determine the frequency, patient demographics, indications, and significant endoscopic findings for patients undergoing BDE.

Design

Retrospective study with a national endoscopic database.

Setting

Diverse clinical practice settings in the United States, including 75% from private practice.

Patients

A total of 591,074 adult patients had upper or lower endoscopy; 66,265 patients (11.2%) with same-day BDE and a subgroup (n = 9067) with a common indication for both upper and lower examinations are the subjects of this analysis.

Main Outcome Measurements

Age, sex, and procedure indication were analyzed in all subjects. Significant endoscopic findings were measured in patients with a single indication of anemia, a positive fecal occult blood test (FOBT), or abdominal pain/dyspepsia (pain) for both upper and lower endoscopy.

Methods

The Clinical Outcomes Research Initiative (CORI) national endoscopic database was analyzed to determine the number of patients who underwent same-day BDE between 2000 and 2004. Patients with a single indication of anemia, positive fecal occult blood test (FOBT), or abdominal pain/dyspepsia (pain) on both EGD and colonoscopy were included for the analysis of endoscopic findings. Significant upper GI findings were defined as suspected malignancy, arteriovenous malformation (AVM), ulcer, Barrett’s esophagus, and stricture. Significant lower GI findings included suspected malignancy, polyp >9 mm, and AVM.

Results

A total of 591,074 patients had upper and/or lower endoscopy; 66,265 patients (11.2%) had same-day BDE. The majority of patients were female (52.1%), and the mean age of patients with BDE was 60.8 years. A total of 6538 patients (9.9%) had anemia, 1169 (1.8%) had a positive FOBT, and 1360 (2.1%) had pain as the sole indication for both examinations. After adjustment for age and sex, significant findings were higher in patients with anemia than in those with pain (odds ratio 1.89; 95% CI, 1.59-2.26) and for patients with positive FOBT versus pain (odds ratio 1.83; 95% CI, 1.48-2.26).

Limitations

Retrospective analysis with possible bias. Fewer patients with pain had significant findings compared to the other two groups (P value <.0001).

Conclusions

More than 10% of patients undergoing upper or lower endoscopy receive same-day BDE. BDE commonly revealed important conditions in patients with anemia or positive FOBT. Bidirectional endoscopy commonly revealed important pathology in patients with anemia or positive FOBT. Patients with pain had a lower prevalence of serious findings compared to the other groups studied. The benefits of BDE in patients with pain are uncertain and require additional investigation.

Le texte complet de cet article est disponible en PDF.

Abbreviations : AVM, BDE, CORI, FOBT, OR


Plan


 DISCLOSURE: All authors disclosed no financial relationships relevant to this publication. D. A. Lieberman is the executive director of CORI, a nonprofit organization that receives funding from federal and industry sources. The CORI database was used in this study. This potential conflict of interest has been reviewed and managed by the OHSU Conflict of Interest in Research Committee.
 Grant Support: This project was supported with funding from NIDDK UO1 CA 89389-01 and the American Cancer Society. In addition, the practice network (Clinical Outcomes Research Initiative) has received support from the following entities to support the infrastructure of the practice-based network: AstraZeneca, Bard International, Pentax USA, ProVation, Endosoft, GIVEN Imaging, and Ethicon. The commercial entities had no involvement in this research. Dr. Lieberman is the executive director of the Clinical Outcomes Research Initiative (CORI), a non-profit organization that receives funding from federal and industry sources. The CORI database is used in this study. This potential conflict of interest has been reviewed and managed by the OHSU Conflict of Interest in Research Committee. This project was supported with funding from NIDDK UO1 CA 89389-01 and the American Cancer Society. In addition, the practice network (CORI) has received support from the following entities to support the infrastructure of the practice-based network: AstraZeneca, Bard International, Pentax USA, ProVation, Endosoft, GIVEN Imaging, and Ethicon. The commercial entities had no involvement in this research.
 If you want to chat with an author of this article, you may contact him at [email protected].


© 2009  American Society for Gastrointestinal Endoscopy. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 69 - N° 2

P. 271-277 - février 2009 Retour au numéro
Article précédent Article précédent
  • A validation study of 3 grading systems to evaluate small-bowel cleansing for wireless capsule endoscopy: a quantitative index, a qualitative evaluation, and an overall adequacy assessment
  • Corey Brotz, Neilanjan Nandi, Mitchell Conn, Constantine Daskalakis, Michael DiMarino, Anthony Infantolino, Leo C. Katz, Theodore Schroeder, David Kastenberg
| Article suivant Article suivant
  • Meshed capillary vessels by use of narrow-band imaging for differential diagnosis of small colorectal polyps
  • Yasushi Sano, Hiroaki Ikematsu, Kuang I. Fu, Fabian Emura, Atsushi Katagiri, Takahiro Horimatsu, Kazuhiro Kaneko, Roy Soetikno, Shigeaki Yoshida

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Elsevier s'engage à rendre ses eBooks accessibles et à se conformer aux lois applicables. Compte tenu de notre vaste bibliothèque de titres, il existe des cas où rendre un livre électronique entièrement accessible présente des défis uniques et l'inclusion de fonctionnalités complètes pourrait transformer sa nature au point de ne plus servir son objectif principal ou d'entraîner un fardeau disproportionné pour l'éditeur. Par conséquent, l'accessibilité de cet eBook peut être limitée. Voir plus

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2026 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.